| Dr Armineh Kajoian, MD | |
|
7801 N Lamar Blvd Ste D8182, Austin, TX 78752-1016 | |
| (512) 868-3376 | |
| (512) 502-5366 |
| Full Name | Dr Armineh Kajoian |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 31 Years |
| Location | 7801 N Lamar Blvd Ste D8182, Austin, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790789154 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0900X | Dermatology - Dermatopathology | J7301 (Texas) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | J7301 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain West Derm - Blackhart Pllc | 1153609813 | 103 |
News Archive
Amgen today announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating Vectibix (panitumumab) in combination with chemotherapy (FOLFOX or FOLFIRI) as a first and second-line treatment for metastatic colorectal cancer (mCRC), respectively, were published online in the Journal of Clinical Oncology.
Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended December 31, 2014 of $109.2 million, or $1.00 per diluted share, and non-GAAP1 net income of $116.5 million, or $1.06 per diluted share. Net income for the same period a year earlier was $75.1 million, or $0.68 per diluted share, and non-GAAP net income was $105.0 million, or $0.95 per diluted share.
When loaded with an anticancer drug, a delivery system based on a novel material called nanosponge is three to five times more effective at reducing tumor growth than direct injection.
The Oregon Insurance Division receives about 100 complaints about long-term-care policies each year, mostly about delays or denials. But now the state's role is increasing, thanks to a law that went into effect this month. The Oregon law requires insurers to process long-term care claims within 30 days when they're not in dispute. It also allows outside review when an insurer decides a person isn't sufficiently disabled for long-term care.
› Verified 3 days ago
| Entity Name | Mountain West Derm - Blackhart Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366018848 PECOS PAC ID: 1153609813 Enrollment ID: O20211018000436 |
News Archive
Amgen today announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating Vectibix (panitumumab) in combination with chemotherapy (FOLFOX or FOLFIRI) as a first and second-line treatment for metastatic colorectal cancer (mCRC), respectively, were published online in the Journal of Clinical Oncology.
Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended December 31, 2014 of $109.2 million, or $1.00 per diluted share, and non-GAAP1 net income of $116.5 million, or $1.06 per diluted share. Net income for the same period a year earlier was $75.1 million, or $0.68 per diluted share, and non-GAAP net income was $105.0 million, or $0.95 per diluted share.
When loaded with an anticancer drug, a delivery system based on a novel material called nanosponge is three to five times more effective at reducing tumor growth than direct injection.
The Oregon Insurance Division receives about 100 complaints about long-term-care policies each year, mostly about delays or denials. But now the state's role is increasing, thanks to a law that went into effect this month. The Oregon law requires insurers to process long-term care claims within 30 days when they're not in dispute. It also allows outside review when an insurer decides a person isn't sufficiently disabled for long-term care.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Armineh Kajoian, MD 4513 Williams Dr, Georgetown, TX 78633-1302 Ph: (512) 930-3909 | Dr Armineh Kajoian, MD 7801 N Lamar Blvd Ste D8182, Austin, TX 78752-1016 Ph: (512) 868-3376 |
News Archive
Amgen today announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating Vectibix (panitumumab) in combination with chemotherapy (FOLFOX or FOLFIRI) as a first and second-line treatment for metastatic colorectal cancer (mCRC), respectively, were published online in the Journal of Clinical Oncology.
Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended December 31, 2014 of $109.2 million, or $1.00 per diluted share, and non-GAAP1 net income of $116.5 million, or $1.06 per diluted share. Net income for the same period a year earlier was $75.1 million, or $0.68 per diluted share, and non-GAAP net income was $105.0 million, or $0.95 per diluted share.
When loaded with an anticancer drug, a delivery system based on a novel material called nanosponge is three to five times more effective at reducing tumor growth than direct injection.
The Oregon Insurance Division receives about 100 complaints about long-term-care policies each year, mostly about delays or denials. But now the state's role is increasing, thanks to a law that went into effect this month. The Oregon law requires insurers to process long-term care claims within 30 days when they're not in dispute. It also allows outside review when an insurer decides a person isn't sufficiently disabled for long-term care.
› Verified 3 days ago
Dr. Joseph Howard Willman, MD Pathology Medicare: Medicare Enrolled Practice Location: 3445 Executive Center Dr, Suite 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 | |
Dr. Robert Domingo, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 12357 A Riata Trace Pkwy, Bldg 5, Ste 100, Thyroid Cytopathology Partners, Austin, TX 78727 Phone: 512-814-0298 Fax: 512-597-2713 | |
Christine Renee Burgess, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3445 Executive Center Drive, Ste 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 | |
Dr. Grace Nightingale Cortez Jackson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3445 Executive Center Drive, Suite 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 | |
Jared Dale Barker, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3445 Executive Center Dr., Ste 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 | |
Vilmos A Thomazy, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 12221 N Mopac Expressway, Namc Department Of Pathology, Austin, TX 78756 Phone: 512-901-1206 Fax: 512-901-1299 | |
Dr. Paul Brooks Gaudin, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3445 Executive Center Dr, Suite 250, Austin, TX 78731 Phone: 512-579-4000 Fax: 512-439-2814 |